A significant increase in lithium levels after concomitant ACE inhibitor administration.
Teitelbaum
M
M
Department of Psychiatry, Cleveland Clinic Foundation, OH.
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D004409:Dyskinesia, Drug-Induced; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D017706:Lisinopril / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008094:Lithium / Q000378:metabolism* / Q000627:therapeutic use / Q000633:toxicity; D008875:Middle Aged; D013881:Thioridazine / Q000009:adverse effects / Q000627:therapeutic use*; D014196:Trazodone / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D008094:Lithium; D017706:Lisinopril; D013881:Thioridazine; D014196:Trazodone